TPTX
Turning Point Therapeutics, Inc.
Director Carl L Gordon bought $6.5M of Turning Point Therapeutics, Inc.
Bought$6,480,000
$18.00Price
360,000Shares
+22%Stake
What TPTX did for a copier
Prices for TPTX after this filing aren't in yet.
Carl L Gordon's record
15 other buys with 3 months of prices since 2016: on average −6.5% against the S&P 500, and 7 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Apr 22. Filed Wed, Apr 24, 2:07 PM ET, during the session. Not investment advice.